Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Medical Director from University of Parma, Italy

Dr. Carmine Siniscalchi is a distinguished medical researcher and physician specializing in internal medicine and cardiovascular diagnostics. With a career rooted in both academic excellence and clinical practice, he has demonstrated a strong commitment to advancing patient care through evidence-based research. Dr. Siniscalchi has authored 87 peer-reviewed publications indexed in Scopus, accumulating 722 citations and an h-index of 13—clear indicators of his research impact in the medical community. His expertise spans multiple domains including non-invasive cardiovascular imaging, thromboembolic disease, geriatric care, and the clinical implications of infectious diseases such as COVID-19. In addition to his research work, he has played a vital academic role as a contract professor and thesis advisor at the University of Parma. Through national and international collaborations, Dr. Siniscalchi has contributed to multidisciplinary studies that bridge clinical diagnostics with population health. His ability to integrate bedside ultrasonography, statistical methodologies, and epidemiological insights into routine practice underscores his innovative and patient-centered approach. With continued scholarly engagement and a forward-thinking mindset, he is well-positioned to make enduring contributions to medical science and education.

Professional Profile

Education

Dr. Carmine Siniscalchi’s academic background is marked by distinction and progressive specialization in the medical sciences. He earned his Medical Degree (Laurea Magistrale in Medicina e Chirurgia) with a score of 110/110 cum laude and special mention from the University of Campania Luigi Vanvitelli in 2009. Following this, he completed his specialization in Internal Medicine at the University of Parma in 2015, again achieving the highest marks with honors. He further pursued a Doctorate (Ph.D.) in Medical Sciences at the Department of Medicine and Surgery, University of Parma, which he completed with distinction in 2017. His doctoral research focused on the comparative efficacy of stress scintigraphy and contrast stress echocardiography in predicting cardiac events. To enhance his methodological expertise, he obtained a Second-Level Master’s Degree in Epidemiology and Biostatistics for Clinical Research from the University of Milano-Bicocca in 2021. This multidisciplinary academic progression has provided him with a strong foundation in both clinical practice and research methodology. Additionally, his classical high school education at Liceo Classico A. Rosmini of Palma Campania enriched his analytical and linguistic abilities, further supporting his academic career.

Professional Experience

Dr. Carmine Siniscalchi has built a multifaceted professional career combining clinical practice, academic teaching, and collaborative research. Since May 2022, he has served as a Contract Professor in Internal Medicine at the University of Parma’s School of Specialization in Cardiovascular Diseases. In this role, he actively contributes to the training of future medical specialists and supervises graduate and postgraduate thesis projects. His professional experience also includes participation in numerous interdisciplinary research projects at both national and international levels, with a strong focus on cardiovascular imaging and diagnostic techniques. Dr. Siniscalchi has held various roles in hospital settings, particularly focusing on internal medicine and geriatric care. His clinical work is deeply informed by his academic pursuits, allowing him to apply advanced diagnostics such as stress echocardiography and bedside ultrasonography in everyday practice. His capacity to balance medical education, clinical responsibility, and active research highlights his comprehensive professional competence. He is also noted for fostering international collaborations, contributing to peer-reviewed publications, and engaging in evidence-based improvements in patient care, particularly for complex cases involving multimorbidity and frailty in elderly populations.

Research Interests

Dr. Carmine Siniscalchi’s research interests are rooted in clinical relevance, focusing on improving diagnostic accuracy and therapeutic strategies in internal medicine. One of his primary interests lies in non-invasive cardiovascular diagnostics, particularly stress echocardiography and scintigraphy, for risk stratification in coronary artery disease. He has also explored the use of bedside ultrasonography as a decision-making tool in hospital settings. His work extends to thromboembolic diseases, both acute and chronic, with emphasis on diagnosis, treatment, and patient outcomes. In recent years, he has actively investigated cardiovascular risk assessment during pregnancy, contributing to studies on maternal cardiac adaptation. A significant portion of his research is also devoted to geriatrics, including the clinical management of frail and multimorbid elderly patients and the impact of hospital-acquired infections, including COVID-19, in this vulnerable population. His background in epidemiology and biostatistics enables him to design and interpret studies that integrate clinical practice with public health implications. Through interdisciplinary collaboration, Dr. Siniscalchi seeks to bridge gaps between imaging technology, clinical decision-making, and long-term patient outcomes. His goal is to foster research that directly improves diagnostic pathways and therapeutic efficacy across diverse patient populations.

Research Skills

Dr. Siniscalchi possesses a robust and diverse set of research skills that align with his multidisciplinary academic and clinical profile. He is adept in epidemiological research design, biostatistics, and data interpretation, all enhanced by his advanced training in epidemiology from the University of Milano-Bicocca. His expertise in cardiovascular imaging, including stress echocardiography, pulse-cancellation echocardiography, and computed tomography, enables him to lead and contribute to high-impact diagnostic studies. He is skilled in conducting bedside ultrasonographic assessments, which he utilizes both as a clinical tool and a subject of investigation. His experience with manuscript writing, peer-reviewed publishing, and academic mentoring reflects his strong academic communication skills. Additionally, he has effectively managed collaborative research projects, integrating input from multi-center teams. His familiarity with scientific databases such as PubMed, Scopus, and Web of Science allows for rigorous literature review and citation analysis. Furthermore, Dr. Siniscalchi has shown proficiency in mentorship, having supervised multiple medical and specialty theses. His ability to bridge clinical insight with methodological precision makes him a valuable contributor to translational medical research.

Awards and Honors

Dr. Carmine Siniscalchi has been consistently recognized for his academic excellence and research acumen throughout his career. He graduated with honors in both his undergraduate and postgraduate medical education, earning a Laurea Magistrale cum laude with special mention and completing his Specialization in Internal Medicine and Ph.D. in Medical Sciences with top honors. While formal awards such as named prizes or competitive grants are not detailed in the available profile, the quality of his academic achievements and consistent recognition by examination commissions reflect a strong professional standing. His invitation to serve as a Contract Professor and his repeated role as thesis advisor indicate trust in his expertise and mentorship within the academic community. His publications in high-impact journals and collaborations with leading researchers further underscore his professional credibility. Being positioned as first, second, or corresponding author in key studies also highlights his leadership in research initiatives. As his career continues to evolve, more formal honors such as awards from scientific societies or recognition at international conferences are likely to follow, given his current trajectory and consistent scholarly output.

Conclusion

Dr. Carmine Siniscalchi exemplifies the qualities of an accomplished medical researcher and educator, with a strong foundation in clinical practice and a deep commitment to advancing diagnostic methodologies and patient care. His academic credentials, professional appointments, and impactful research contributions—particularly in cardiovascular diagnostics and internal medicine—make him a compelling candidate for recognition such as the Best Researcher Award. Through active involvement in teaching, publication, and collaborative research, he has demonstrated a balance of scholarly rigor and clinical pragmatism. While there is scope for further recognition through competitive awards and international grants, Dr. Siniscalchi’s current record already reflects significant contributions to the field. His ability to mentor students, collaborate across institutions, and address critical healthcare issues—ranging from cardiovascular risk to aging populations—positions him as a leader in translational medical research. In summary, Dr. Siniscalchi not only meets the standards of research excellence but also brings a humanistic and evidence-driven perspective to medicine, making him a strong nominee for distinguished honors in his field.

Publications Top Notes

  1. Title: Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism
    Authors: Carmine Siniscalchi, Tiziana Meschi, Pierpaolo Di Micco, Joaquín Alfonso-Megido, Manuel Monreal
    Journal: JAMA Network Open
    Year: 2025

  2. Title: Venous Thromboembolism in Patients Aged ≥90 Years: Trends in Clinical Features, Treatment, and Outcomes—RIETE Registry
    Authors: Ludovic Lafaie, Géraldine Poénou, Olivier Hanon, Alberto Rivera-Gallego, Ana Rodríguez-Cobo
    Journal: Journal of the American Geriatrics Society
    Year: 2025
    Citations: 2

  3. Title: Predictors of Acute Myocardial Infarction: A Machine Learning Analysis After a 7-Year Follow-Up
    Authors: Marco Casciaro, Pierpaolo Di Micco, Alessandro Tonacci, Sebastiano Gangemi, E. Imbalzano
    Journal: Clinics and Practice
    Year: 2025

  4. Title: Integrated Lung, Diaphragm and Lower Limb Muscular Ultrasound: Clinical Correlations in Geriatric Patients with Acute Respiratory Illness
    Authors: Nicoletta Cerundolo, Carmine Siniscalchi, Chukwuma Okoye, Andrea Nouvenne, Andrea Ticinesi
    Journal: Diagnostics
    Year: 2025

  5. Title: Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry
    Authors: Carmine Siniscalchi, Pierpaolo Di Micco, Antonella Tufano, Pablo Javier Marchena, Mar Martín del Pozo
    Year: 2025

  6. Title: The Prognostic Value of Clinical Frailty Scale in COVID-19 Pneumonia Across Different Pandemic Phases: A Comparison Between the First and the Fourth Wave
    Authors: Carmine Siniscalchi, Andrea Ticinesi, Angela Guerra, Emanuela Porro, Tiziana Meschi
    Journal: Frontiers in Medicine
    Year: 2025

  7. Title: Proprotein Convertase Subtilisin/Kexin Type 9: A Promising Marker of Cardiovascular Risk in Post-Menopausal Diabetic Women in Primary Prevention
    Authors: Michelangelo Rottura, Maria Antonietta Barbieri, Carmine Siniscalchi, Natasha Irrera, E. Imbalzano
    Journal: Frontiers in Medicine
    Year: 2025

  8. Title: Gut Microbiome and Bone Health: Update on Mechanisms, Clinical Correlations, and Possible Treatment Strategies
    Authors: Andrea Ticinesi, Carmine Siniscalchi, Tiziana Meschi, A. Nouvenne
    Year: 2025
    Citations: 1

  9. Title: Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
    Authors: Carmine Siniscalchi, Francesca Futura Bernardi, Pierpaolo Di Micco, Tiziana Meschi, Ugo Trama
    Year: 2025

 

Heba Jalloun | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Heba Jalloun | Medicine and Dentistry | Best Researcher Award

King Fahd Armed Forces Hospital from Saudi Arabia

Dr. Heba Essam Jalloun is a highly accomplished consultant in colorectal, minimally invasive, and robotic surgery, currently based at King Fahd Armed Forces Hospital (KFAFH) in Jeddah, Saudi Arabia. With over two decades of extensive clinical, academic, and research experience, Dr. Jalloun has demonstrated a steadfast commitment to the advancement of surgical practice, training, and innovation in her field. She earned her Bachelor’s degree in Medicine and Surgery from King Abdul-Aziz University in 2000, followed by the Saudi Specialty Certificate in General Surgery in 2008. Her international training includes two prestigious fellowships in South Korea focusing on minimally invasive, laparoscopic, robotic, oncology, and pelvic floor surgeries. Beyond her clinical responsibilities, she actively participates in training future surgeons as the Director of the General Surgery Saudi Board Residency Program at KFAFH. Dr. Jalloun is widely recognized for her contributions as a speaker at national and international conferences, as well as her active participation in surgical societies across Saudi Arabia, Europe, and Asia. Her work during the COVID-19 pandemic as a frontliner and her extensive involvement in global research collaborations further emphasize her dedication to both patient care and the academic community.

Professional Profile

Education

Dr. Heba Jalloun’s educational foundation is rooted in excellence and international exposure. She began her medical education at King Abdul-Aziz University, where she earned her Bachelor’s degree in Medicine and General Surgery (MBChB) between 1994 and 2000. After passing the Saudi License Exam in 2000, she pursued her residency in General Surgery through the Saudi Board program, completing her Saudi Specialty Certificate in General Surgery (SSC-SURG) in 2008. Her postgraduate training was distinguished by a strong focus on advanced surgical techniques, particularly in minimally invasive procedures. She furthered her expertise through two consecutive fellowships in South Korea: one in Minimal Invasive Surgery, Laparoscopic & Robotic Surgery for Colorectal Diseases (2015–2016), and the second in Oncology, Proctology, and Pelvic Floor Surgery (2017). These fellowships were undertaken at the Catholic University of Korea, Seoul St. Mary’s Hospital, providing her with global perspectives and high-level surgical training. Dr. Jalloun also acquired numerous certifications including ATLS instructor, Basic Surgical Skills instructor, Advanced Cardiac Life Support, and the Train of Trainer (TOT) program. Her dedication to continuous professional development is further evident through her involvement in structured surgical courses and certifications that support both clinical excellence and teaching proficiency.

Professional Experience

Dr. Heba Jalloun’s professional career spans over two decades of dedicated service, with a significant focus on general, colorectal, and robotic surgery. She began her journey in clinical practice as a resident in family medicine from 2001 to 2003, then transitioned into general surgery residency at Northwest Armed Forces Hospital and King Abdulaziz & Oncology Center from 2003 to 2008. After receiving her board certification, she was appointed as a Registrar and later an Assistant Consultant in General Surgery at KFAFH. Her expertise and leadership were recognized as she advanced to the roles of General Surgery Consultant in 2014 and Colorectal, Minimally Invasive, and Robotic Surgery Consultant in 2018. In 2022, she was appointed Director of the Saudi Board General Surgery Residency Program at KFAFH. Alongside clinical duties, Dr. Jalloun has led and organized numerous simulation-based training courses, contributed significantly to resident education, and participated in advanced surgical workshops both nationally and internationally. Her role during the COVID-19 pandemic as a frontliner and key investigator in global surgical research further highlights her dynamic and compassionate leadership. She is also an active member of surgical societies in Saudi Arabia and abroad, bridging international best practices with local healthcare advancements.

Research Interests

Dr. Heba Jalloun’s research interests are aligned closely with her clinical expertise in colorectal surgery, minimally invasive techniques, and oncology. She is deeply engaged in advancing surgical methodologies through evidence-based studies and is particularly focused on Enhanced Recovery After Surgery (ERAS) protocols, outcomes of laparoscopic procedures, and the management of colorectal diseases. Her international collaborations reflect her commitment to global health challenges, especially in the context of the COVID-19 pandemic, where she co-authored several high-impact publications addressing surgical delays, postoperative complications, and vaccine safety related to surgical outcomes. Additionally, she is interested in surgical education, clinical audits, and quality improvement projects—particularly those improving patient discharge efficiency and postoperative recovery. Dr. Jalloun has also explored surgical techniques in emergency abdominal procedures and rare case reports, including drug addiction among high school students. Her current and ongoing research includes hospital-based projects, international multicenter cohort studies, and case series publications. Through this multifaceted research approach, Dr. Jalloun aims to bridge gaps between clinical practice and academic inquiry, ultimately contributing to improved patient safety, surgical precision, and innovation in healthcare systems across the region and globally.

Research Skills

Dr. Heba Jalloun possesses a strong portfolio of research skills encompassing clinical study design, data collection, analysis, publication, and academic presentations. She has served as a principal investigator for several international multicenter studies focused on elective cancer surgery, acute cholecystitis, and surgical outcomes during the COVID-19 pandemic. Her contributions demonstrate proficiency in conducting prospective cohort studies, managing collaborative global datasets, and interpreting clinical implications across diverse healthcare settings. Additionally, Dr. Jalloun is skilled in writing and reviewing scientific manuscripts, poster presentations, and case reports. Her research on ERAS protocols, laparoscopic surgery outcomes, and oncologic safety has been published in respected international journals. She actively contributes to hospital-based quality improvement projects and is proficient in coordinating multidisciplinary research teams. Dr. Jalloun’s training experience also equips her with excellent skills in presenting at international symposiums, conducting workshops, and teaching evidence-based surgical practices. Her ability to integrate research into clinical practice makes her an asset to both academic and medical institutions. Furthermore, her dedication to mentorship and supervision of trainees in research-related tasks reinforces her role as a leader in academic medicine and clinical education.

Awards and Honors

Dr. Heba Jalloun has received multiple awards and honors in recognition of her clinical excellence, teaching capabilities, and service to the healthcare community. She was honored with the Best Instructor and Teacher award at King Fahd Armed Forces Hospital (KFAFH) for the academic year 2019–2020, reflecting her impactful contributions to surgical education. Earlier in her career, she was recognized as the Best Senior Registrar in 2010–2011, showcasing her exceptional performance during residency. Her role as an instructor in ATLS and Basic Surgical Skills courses since 2005 further highlights her longstanding commitment to surgical training. Dr. Jalloun received certificates of appreciation for her contributions to patient safety and experience in both 2021 and 2023, underlining her dedication to improving healthcare quality. During the COVID-19 pandemic, she was acknowledged for her invaluable service as a frontliner and key investigator in international research collaborations. Additionally, she has been commended for her participation as a speaker in numerous national and international symposiums. These accolades collectively reflect her multifaceted contributions as a surgeon, educator, researcher, and leader committed to advancing the field of surgery and patient care at both national and global levels.

Conclusion

In conclusion, Dr. Heba Essam Jalloun exemplifies the qualities of a distinguished surgeon, educator, and researcher, making her a strong candidate for the Best Researcher Award. Her career demonstrates an exceptional balance between clinical practice, academic leadership, and impactful research contributions. Through her international training in advanced surgical techniques and ongoing participation in global collaborative studies, she has significantly enriched both patient outcomes and medical knowledge. Her work during the COVID-19 pandemic, alongside her numerous publications and hospital projects, highlights her commitment to addressing real-world challenges with scientific rigor. Dr. Jalloun’s leadership in surgical education, evident from her role as Director of the Saudi Board Residency Program, further establishes her as a mentor and role model for future generations of surgeons. With multiple awards recognizing her teaching, service, and research, she has shown unwavering dedication to excellence in healthcare. While her work is already commendable, expanding her independent research leadership and engaging in broader interdisciplinary projects could further enhance her impact. Overall, Dr. Jalloun’s credentials and achievements reflect not only her expertise but also her vision for continuous innovation and improvement in surgery and medical education. She is a highly deserving candidate for this prestigious recognition.

Publications Top Notes

  • Title: Influence of the Enhanced Recovery After Surgery Protocol on Postoperative Inflammation and Short-Term Postoperative Surgical Outcomes After Colorectal Cancer Surgery

  • Authors: Jalloun Heba Essam (H.E.), Lee In Kyu (I.K.), Kim Min-ki (M.), Lee Yoon-suk (Y.), Jeon Hae-myung (H.)

  • Year: 2020

  • Citations: 19

Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Gynaecologist at Walter Sisulu University, South Africa

Dr. M. Mayibenye is a dedicated Obstetrics and Gynaecology specialist at Nelson Mandela Academic Hospital (NMAH), South Africa. With a strong academic foundation, a proven record of research in maternal health, and a commitment to advancing clinical practice, Dr. Mayibenye stands out as an emerging leader in the field. She has presented her work at prominent national conferences, including SASUOG and SAATOG, contributing to critical discussions on obstetric care. Her research focuses on improving surgical outcomes for repeat cesarean sections, with practical applications that enhance patient care. Dr. Mayibenye is also actively involved in professional organizations like HPCSA, SAMA, and ISUOG, further enriching her academic and clinical journey.

Professional Profile

Education

Dr. Mayibenye’s academic achievements include completing her MBChB in 2015 and MMED in 2022, both from Walter Sisulu University (WSU). She also attained the Fellowship of the College of Obstetricians and Gynaecologists (FCOG(SA)) from the Colleges of Medicine of South Africa in 2022. These qualifications reflect her rigorous training and expertise in the field. Her journey began with matriculation from Dimanda Secondary School in 2009. Dr. Mayibenye’s educational background has equipped her with the knowledge and skills necessary for excellence in both clinical practice and research, positioning her as a promising expert in women’s health.

Professional Experience

Dr. Mayibenye has gained substantial clinical experience since joining NMAH as a community service doctor in 2018. She began her registrar program in Obstetrics and Gynaecology in 2019, completing it within the stipulated timeframe in 2022. Since then, she has been working as a specialist at NMAH, contributing to the department through her clinical expertise and dedication to maternal care. Her professional experience also includes completing her internship at NMAH in 2017 and community service in 2018. Through her roles, Dr. Mayibenye has demonstrated exceptional commitment to improving women’s health outcomes, combining her clinical skills with research insights to deliver impactful results.

Research Interests

Dr. Mayibenye’s research interests focus on improving outcomes in obstetric surgeries, particularly in predicting complications during repeat cesarean sections. Her MMED research explored pre-operative prediction of severe intraperitoneal adhesions using clinical signs and sliding sign, addressing a critical need for safer surgical planning. This area of interest reflects her dedication to maternal health and patient safety, with a specific focus on evidence-based approaches to minimize surgical risks. Dr. Mayibenye is also passionate about advancing diagnostic methods and contributing to the broader understanding of obstetric care challenges in resource-constrained settings.

Research Skills

Dr. Mayibenye possesses advanced research skills honed through her academic and clinical work. She is proficient in designing and conducting clinical studies, data analysis, and translating findings into practical applications. Her expertise includes presenting complex research findings at national conferences such as SASUOG and SAATOG, where she has effectively communicated her work to peers and experts. Dr. Mayibenye is skilled in systematic literature reviews, clinical data interpretation, and the use of diagnostic tools for surgical prediction. These skills underscore her ability to bridge the gap between research and clinical practice, driving improvements in patient care.

Awards and Honors

Dr. Mayibenye’s academic and professional journey reflects numerous milestones of achievement. Notable accomplishments include her completion of the MMED program and earning the prestigious FCOG(SA) designation from CMSA in 2022. Her selection to present research at leading conferences such as SASUOG, SAATOG, and the 41st Conference on Priorities in Perinatal Care in Southern Africa highlights her recognition as a contributor to critical discussions in obstetrics. Dr. Mayibenye’s continuous involvement in professional organizations like SAMA and ISUOG further emphasizes her dedication to advancing her field through collaboration and knowledge dissemination.

Conclusion

Dr. M. Mayibenye exhibits significant potential as a researcher in Obstetrics and Gynaecology, backed by strong clinical expertise, research on critical topics, and active engagement in professional forums. To excel in competitions for the Best Researcher Award, additional publications in high-impact journals, diversification of research focus, and increased international exposure could strengthen their candidacy. Overall, Dr. Mayibenye is a suitable candidate with promising contributions and growth potential in the field.

 

 

Minji Jung | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Minji Jung | Health Professions | Best Researcher Award

Postdoctoral Scholar at Stanford University Medical Center, United States

Minji Jung is a prominent researcher with expertise in cancer epidemiology, pharmacoepidemiology, and risk factors for chronic diseases such as kidney cancer and cardiovascular conditions. She currently serves as a Postdoctoral Scholar at the Urologic Cancer Epidemiology Lab at Stanford University School of Medicine. Minji has an extensive academic background, earning a PhD in Clinical Pharmacoepidemiology and holding a PharmD degree from Ajou University, South Korea. Her research has spanned multiple high-impact areas, including kidney cancer, cardiovascular diseases, and dementia, with a focus on real-world data analysis. Minji has secured significant research funding, led interdisciplinary projects, and earned numerous awards, underscoring her substantial contributions to health sciences. Her work integrates diverse data sets, cutting-edge statistical methods, and collaborative partnerships, making her a leading figure in her field.

Professional Profile

Education:

Minji Jung holds a PharmD from Ajou University in South Korea, completed in 2016, where she also earned her PhD in Clinical Pharmacoepidemiology in 2021. During her doctoral studies, Minji focused on evaluating the pleiotropic effects of statin therapy, specifically investigating its potential role in preventing hemorrhagic stroke and dementia using Korean nationwide health insurance data. She has further honed her expertise as a Research Fellow at the University of California, San Francisco, in 2021-2022, specializing in pharmacoepidemiology related to cardiovascular disease. Minji’s education has been marked by a strong foundation in clinical pharmacy, epidemiology, and data analytics, laying the groundwork for her current focus on urologic cancer and cardio-oncology research.

Professional Experience:

Minji Jung’s professional journey includes roles in academia and research, where she has made significant strides in clinical pharmacy and epidemiology. She is currently a Postdoctoral Scholar at Stanford University’s Urologic Cancer Epidemiology Lab, where she focuses on cancer epidemiology, pharmacoepidemiology, and kidney cancer research. Previously, she served as a Research Fellow at the University of California, San Francisco, contributing to studies on cardiovascular disease and medication adherence. Minji’s early research experience includes working at Ajou University, South Korea, where she contributed to pharmacoepidemiological projects examining the effects of statin use and its association with stroke and dementia. Her expertise spans across both clinical and epidemiological settings, enabling her to integrate real-world data into her research and offering valuable insights into chronic disease prevention and management.

Research Interests:

Minji Jung’s research interests are centered on cancer epidemiology, pharmacoepidemiology, and the intersection of chronic diseases such as kidney cancer, cardiovascular conditions, and dementia. Her work focuses on understanding the epidemiology and risk factors associated with kidney cancer, analyzing large health data sets to explore connections between metabolic syndrome and cancer incidence. Additionally, Minji is deeply invested in survivorship and psycho-oncology, exploring the mental and physical health outcomes of patients diagnosed with cancer. Her research also delves into cardio-oncology, investigating the cardiovascular risks of cancer patients, especially those undergoing treatment. By using advanced statistical methods and diverse global data sets, Minji aims to improve the prevention, diagnosis, and treatment of chronic diseases, with a focus on kidney cancer and its broader implications for public health.

Research Skills:

Minji Jung possesses advanced research skills, particularly in epidemiological methods, pharmacoepidemiology, and statistical analysis. She is adept at handling large, diverse data sets, such as SEER, UK Biobank, and MarketScan® data, and has expertise in applying a variety of statistical techniques, including logistic regression, survival analysis, propensity score matching, and Cox regression models. Minji is skilled in utilizing real-world data to study the epidemiology of chronic diseases and their interactions with medications. Her proficiency in data analysis is complemented by her ability to integrate findings from multiple disciplines, allowing her to draw meaningful conclusions that influence clinical and public health policies. Minji is also experienced in project management, having led her own research initiatives, and is well-versed in the application of innovative research methods to investigate complex health issues.

Awards and Honors:

Minji Jung has received numerous awards in recognition of her exceptional research contributions. Notably, she was honored with the Poster Award from the Western Section of the American Urological Association in 2024 and was selected as a Notable Scientist by the Korean Biological Research Information Center in 2023. She also won the Oral Presentation Award at the 24th Annual Spring Research Seminar at the University of California, San Francisco, in 2022. Minji’s achievements are further highlighted by an Oral Presentation Award from the Pharmaceutical Society of Korea in 2019, as well as a Certificate of Commendation from the Suwon Pharmaceutical Association in 2018. These accolades reflect the high regard in which she is held by the scientific community, emphasizing her impactful research in the fields of epidemiology and pharmacoepidemiology.

Conclusion

Minji Jung has demonstrated exceptional research capabilities in areas that have profound implications for public health, particularly in cancer epidemiology and pharmacoepidemiology. Her leadership in securing research grants and contributing to significant health-related findings sets her apart as a candidate for the Best Researcher Award. While there are areas that could be further strengthened, particularly in terms of broadening her influence in the public sphere and maximizing publication impact, her accomplishments thus far make her a highly deserving nominee for the award.

Publication Top Notes

  • Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia
    Authors: M Jung, S Lee
    Year: 2019
    Citations: 22
  • Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease
    Authors: MY Kim, M Jung, Y Noh, S Shin, CH Hong, S Lee, YS Jung
    Year: 2020
    Citations: 18
  • Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a population-based cohort study in Korea
    Authors: M Jung, S Lee
    Year: 2020
    Citations: 10
  • Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide
    Authors: G Jin, HV Ngo, J Wang, JH Cui, QR Cao, C Park, M Jung, BJ Lee
    Year: 2022
    Citations: 8
  • Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea
    Authors: M Jung, E Choo, S Lee
    Year: 2020
    Citations: 7
  • Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data
    Authors: E Choo, M Jung, J Shin, S Lee
    Year: 2021
    Citations: 5
  • Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation
    Authors: YM Sohn, RE Ko, HJ Park, E Choo, M Jung, S Lee, K Jeon
    Year: 2023
    Citations: 1
  • A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean National Health Insurance Claims Data
    Authors: M Jung, E Choo, S Lee
    Year: 2023
    Citations: 1
  • Effects of Postprandial Factors and Second Meal Intake Time on Bioequivalence Investigation of Tadalafil-Loaded Orodispersible Films in Human Volunteers
    Authors: SJ Park, MC Gil, BS Lee, M Jung, BJ Lee
    Year: 2024
    Citations: Not listed yet
  • Air pollution mixture associated with oxidative stress exacerbation and symptoms deterioration in allergic rhinitis patients: Evidence from a panel study
    Authors: J Li, H Wu, W Xing, X Li, Z Han, R Ji, Z Deng, M Jung, S Sun, BI Chung, …
    Year: 2024